Current standards and new innovative approaches for treatment of pancreatic cancer
Thierry Conroy(Inserm), Michel Ducreux(Université Paris-Saclay), Jean‐Luc Van Laethem(Deventer Ziekenhuis), Caroline Caramella(Institut Gustave Roussy), Ahmet Ayav(Centre Hospitalier Régional et Universitaire de Nancy), Jean‐Baptiste Bachet(Sorbonne Université), Aurélien Lambert(Institut de Cancérologie de Lorraine), Raphaël Maréchal(Université Libre de Bruxelles), F. Huguet(Sorbonne Université)
Cited by 186
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k